Trial intelligence / Profile preview

Tamsulosin Monotherapy vs Combination with Tadalafil in BPH

NCT07722884Recruiting

Sponsor
Ain Shams University
Start
Jul 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Randomised trial of tadalafil in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Ain Shams University. Primary endpoint: International Prostate Symptom Score at 12 weeks. Started Jul 2026; status: recruiting.

02

Drugs

tadalafil
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT07722884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07722884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call